These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 32676595)
1. N and O glycosylation of the SARS-CoV-2 spike protein. Sanda M; Morrison L; Goldman R bioRxiv; 2020 Jul; ():. PubMed ID: 32676595 [TBL] [Abstract][Full Text] [Related]
2. N- and O-Glycosylation of the SARS-CoV-2 Spike Protein. Sanda M; Morrison L; Goldman R Anal Chem; 2021 Feb; 93(4):2003-2009. PubMed ID: 33406838 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous enrichment and separation of neutral and sialyl glycopeptides of SARS-CoV-2 spike protein enabled by dual-functionalized Ti-IMAC material. Huang J; Wang D; Shipman RD; Zhu Z; Liu Y; Li L Anal Bioanal Chem; 2021 Dec; 413(29):7295-7303. PubMed ID: 34155551 [TBL] [Abstract][Full Text] [Related]
4. Site-Specific Glycosylation Patterns of the SARS-CoV-2 Spike Protein Derived From Recombinant Protein and Viral WA1 and D614G Strains. Tian Y; Parsons LM; Jankowska E; Cipollo JF Front Chem; 2021; 9():767448. PubMed ID: 34869209 [TBL] [Abstract][Full Text] [Related]
6. Capturing a Crucial 'Disorder-to-Order Transition' at the Heart of the Coronavirus Molecular Pathology-Triggered by Highly Persistent, Interchangeable Salt-Bridges. Roy S; Ghosh P; Bandyopadhyay A; Basu S Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214759 [TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity. Sasaki M; Toba S; Itakura Y; Chambaro HM; Kishimoto M; Tabata K; Intaruck K; Uemura K; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H mBio; 2021 Aug; 12(4):e0141521. PubMed ID: 34425707 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive O-Glycosylation Analysis of the SARS-CoV-2 Spike Protein with Biomimetic Trp-Arg Materials. Dong X; Chen C; Yan J; Zhang X; Li X; Liang X Anal Chem; 2021 Aug; 93(30):10444-10452. PubMed ID: 34284575 [TBL] [Abstract][Full Text] [Related]
9. Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike. Mehdipour AR; Hummer G Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33903171 [TBL] [Abstract][Full Text] [Related]
10. Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective. Li W Biophys Chem; 2020 Sep; 264():106420. PubMed ID: 32622243 [TBL] [Abstract][Full Text] [Related]
11. Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation. Zhang L; Mann M; Syed Z; Reynolds HM; Tian E; Samara NL; Zeldin DC; Tabak LA; Ten Hagen KG bioRxiv; 2021 Feb; ():. PubMed ID: 33564758 [TBL] [Abstract][Full Text] [Related]
12. O-Linked Sialoglycans Modulate the Proteolysis of SARS-CoV-2 Spike and Likely Contribute to the Mutational Trajectory in Variants of Concern. Gonzalez-Rodriguez E; Zol-Hanlon M; Bineva-Todd G; Marchesi A; Skehel M; Mahoney KE; Roustan C; Borg A; Di Vagno L; Kjær S; Wrobel AG; Benton DJ; Nawrath P; Flitsch SL; Joshi D; González-Ramírez AM; Wilkinson KA; Wilkinson RJ; Wall EC; Hurtado-Guerrero R; Malaker SA; Schumann B ACS Cent Sci; 2023 Mar; 9(3):393-404. PubMed ID: 36968546 [TBL] [Abstract][Full Text] [Related]
13. O-Glycosylation Landscapes of SARS-CoV-2 Spike Proteins. Zhang Y; Zhao W; Mao Y; Chen Y; Zheng S; Cao W; Zhu J; Hu L; Gong M; Cheng J; Yang H Front Chem; 2021; 9():689521. PubMed ID: 34552909 [TBL] [Abstract][Full Text] [Related]
14. Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate. Zhang XY; Guo J; Wan X; Zhou JG; Jin WP; Lu J; Wang WH; Yang AN; Liu DX; Shi ZL; Yuan ZM; Li XG; Meng SL; Duan K; Wang ZJ; Yang XM; Shen S Emerg Microbes Infect; 2020 Dec; 9(1):2653-2662. PubMed ID: 33232205 [TBL] [Abstract][Full Text] [Related]
15. Structures and dynamics of the novel S1/S2 protease cleavage site loop of the SARS-CoV-2 spike glycoprotein. Lemmin T; Kalbermatter D; Harder D; Plattet P; Fotiadis D J Struct Biol X; 2020; 4():100038. PubMed ID: 33043289 [TBL] [Abstract][Full Text] [Related]
16. Analysis of glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein. Zhang S; Go EP; Ding H; Anang S; Kappes JC; Desaire H; Sodroski J bioRxiv; 2021 Apr; ():. PubMed ID: 33821278 [TBL] [Abstract][Full Text] [Related]
17. Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants. van Oosten L; Altenburg JJ; Fougeroux C; Geertsema C; van den End F; Evers WAC; Westphal AH; Lindhoud S; van den Berg W; Swarts DC; Deurhof L; Suhrbier A; Le TT; Torres Morales S; Myeni SK; Kikkert M; Sander AF; de Jongh WA; Dagil R; Nielsen MA; Salanti A; Søgaard M; Keijzer TMP; Weijers D; Eppink MHM; Wijffels RH; van Oers MM; Martens DE; Pijlman GP mBio; 2021 Oct; 12(5):e0181321. PubMed ID: 34634927 [TBL] [Abstract][Full Text] [Related]
18. A Linkage-specific Sialic Acid Labeling Strategy Reveals Different Site-specific Glycosylation Patterns in SARS-CoV-2 Spike Protein Produced in CHO and HEK Cell Substrates. Wang Q; Wang Y; Yang S; Lin C; Aliyu L; Chen Y; Parsons L; Tian Y; Jia H; Pekosz A; Betenbaugh MJ; Cipollo JF Front Chem; 2021; 9():735558. PubMed ID: 34631661 [TBL] [Abstract][Full Text] [Related]
19. Structural and functional modelling of SARS-CoV-2 entry in animal models. Brooke GN; Prischi F Sci Rep; 2020 Sep; 10(1):15917. PubMed ID: 32985513 [TBL] [Abstract][Full Text] [Related]
20. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states. Peters MH; Bastidas O; Kokron DS; Henze CE PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]